Visco Vision Inc. AI Stock Analysis
Visco Vision Inc. (6782) AI Stock Analysis
Visco Vision Inc.
(TWSE:6782)
Strong profitability, favorable technical momentum, and reasonable valuation drive the score higher. The main constraints are negative free cash flow and increased leverage, which temper the otherwise favorable investment profile.
Visco Vision Inc. (6782) vs. SPDR S&P 500 ETF (SPY)
- Market Cap
- TWD 17.64B
- Dividend Yield
- 2.97%
- Average Volume (3M)
- 526.42K
- Price to Earnings (P/E)
- 15.1
- Beta (1Y)
- 0.42
- Revenue Growth
- 23.29%
- EPS Growth
- 55.47%
- Country
- TW
- Employees
- 16,368
- Sector
- General
- Sector Strength
- 55
- Industry
- Medical - Instruments & Supplies
Visco Vision Inc. Business Overview & Revenue Model
Company Description
Visco Vision, Inc. engages in the production and sale of disposable soft contact lenses, It specializes in design and production of disposable contact lenses with different water content and oxygen permeability According to the same use cycle, it can...
Visco Vision Inc. Financial Statement Overview
Summary
Strong profitability and improving margins support the score, while the solid balance sheet is offset by materially higher debt. Negative TTM free cash flow and weaker cash conversion are the main financial risks.
Income Statement
90Very PositiveBalance Sheet
78PositiveCash Flow
57Neutral| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Mar 2023 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 5.02B | 4.22B | 3.67B | 2.40B | 2.78B | 1.96B |
| Gross Profit | 2.34B | 1.91B | 1.43B | 857.16M | 1.23B | 839.34M |
| EBITDA | 2.04B | 1.67B | 1.21B | 733.59M | 1.08B | 667.51M |
| Net Income | 1.18B | 886.61M | 636.47M | 301.61M | 617.43M | 443.63M |
Balance Sheet | ||||||
| Total Assets | 8.19B | 6.00B | 5.30B | 4.72B | 5.29B | 3.13B |
| Cash, Cash Equivalents and Short-Term Investments | 838.13M | 795.70M | 805.26M | 720.77M | 1.81B | 351.00M |
| Total Debt | 1.84B | 481.89M | 844.32M | 1.08B | 1.42B | 1.21B |
| Total Liabilities | 3.32B | 1.56B | 1.59B | 1.74B | 2.19B | 2.02B |
| Stockholders Equity | 4.85B | 4.42B | 3.70B | 2.96B | 3.08B | 1.11B |
Cash Flow | ||||||
| Free Cash Flow | -406.37M | 829.29M | 605.49M | -97.41M | 48.23M | -304.00M |
| Operating Cash Flow | 1.58B | 1.37B | 1.12B | 353.06M | 985.13M | 607.66M |
| Investing Cash Flow | -2.08B | -745.34M | -512.41M | -938.85M | -963.01M | -748.19M |
| Financing Cash Flow | 360.03M | -699.02M | -418.10M | -666.82M | 1.41B | 287.54M |
Visco Vision Inc. Peers Comparison
Overall Rating
TW:678281Outperform
TW:410460.5Neutral
TW:497755Neutral
TW:336240Underperform
TW:314928Underperform
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| 81Outperform | TWD 18.14B | 15.06 | ― | 2.97% | 23.29% | 55.47% | |
| 61Neutral | TWD 13.58B | 14.58 | ― | 5.97% | 11.09% | 7.11% | |
| Sector * | 55Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% |
| 55Neutral | TWD 17.02B | 55.79 | ― | 1.10% | -25.66% | -39.19% | |
| 40Underperform | TWD 18.28B | -74.38 | ― | 0.80% | -2.57% | -1044.10% | |
| 28Underperform | TWD 17.75B | -32.84 | ― | ― | 7.57% | 16.45% |
* General Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| TW:6782 | Visco Vision Inc. | 282.50 | 113.15 | 66.81% | |
| TW:3149 | G-Tech Optoelectronics Corporation | 68.20 | 33.97 | 99.23% | |
| TW:3362 | Ability Opto-Electronics Technology Co., Ltd. | 128.00 | 32.89 | 34.58% | |
| TW:4104 | Excelsior Medical Co., Ltd. | 72.00 | -5.81 | -7.47% | |
| TW:4977 | PCL Technologies, Inc. | 186.00 | 84.35 | 82.98% | |
| TW:7917 | Centera Photonics Inc | 311.00 | -99.00 | -24.15% |
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Nov 09, 2026
